These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15233622)

  • 61. From Pap to ApUp.
    Collier RJ
    Cell Immunol; 1982 Jan; 66(1):17-23. PubMed ID: 7044562
    [No Abstract]   [Full Text] [Related]  

  • 62. NAD on the rise again.
    Ziegler M; Nikiforov AA
    Nat Metab; 2020 Apr; 2(4):291-292. PubMed ID: 32694607
    [No Abstract]   [Full Text] [Related]  

  • 63. Accounting for NAD Concentrations in Genome-Scale Metabolic Models Captures Important Metabolic Alterations in NAD-Depleted Systems.
    Sauter R; Sharma S; Heiland I
    Biomolecules; 2024 May; 14(5):. PubMed ID: 38786009
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nicotinamide adenine dinucleotide metabolism in the immune response, autoimmunity and inflammageing.
    Navarro MN; Gómez de Las Heras MM; Mittelbrunn M
    Br J Pharmacol; 2022 May; 179(9):1839-1856. PubMed ID: 33817782
    [TBL] [Abstract][Full Text] [Related]  

  • 65. NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation.
    Audrito V; Messana VG; Deaglio S
    Front Oncol; 2020; 10():358. PubMed ID: 32266141
    [TBL] [Abstract][Full Text] [Related]  

  • 66. NAD metabolites interfere with proliferation and functional properties of THP-1 cells.
    Petin K; Weiss R; Müller G; Garten A; Grahnert A; Sack U; Hauschildt S
    Innate Immun; 2019 Jul; 25(5):280-293. PubMed ID: 31053044
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HIV Disease Progression: Overexpression of the Ectoenzyme CD38 as a Contributory Factor?
    Rodríguez-Alba JC; Abrego-Peredo A; Gallardo-Hernández C; Pérez-Lara J; Santiago-Cruz W; Jiang W; Espinosa E
    Bioessays; 2019 Jan; 41(1):e1800128. PubMed ID: 30537007
    [TBL] [Abstract][Full Text] [Related]  

  • 68. β-Nicotinamide Adenine Dinucleotide (β-NAD) Inhibits ATP-Dependent IL-1β Release from Human Monocytic Cells.
    Hiller SD; Heldmann S; Richter K; Jurastow I; Küllmar M; Hecker A; Wilker S; Fuchs-Moll G; Manzini I; Schmalzing G; Kummer W; Padberg W; McIntosh JM; Damm J; Zakrzewicz A; Grau V
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642561
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Scant Extracellular NAD Cleaving Activity of Human Neutrophils is Down-Regulated by fMLP via FPRL1.
    Hasan MA; Sultan MT; Ahn WG; Kim YJ; Jang JH; Hong CW; Song DK
    Korean J Physiol Pharmacol; 2014 Dec; 18(6):497-502. PubMed ID: 25598664
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of NAD at purine receptors in isolated blood vessels.
    Alefishat E; Alexander SP; Ralevic V
    Purinergic Signal; 2015 Mar; 11(1):47-57. PubMed ID: 25315718
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nicotinamide Phosphoribosyltransferase in Human Diseases.
    Zhang LQ; Heruth DP; Ye SQ
    J Bioanal Biomed; 2011 Jan; 3():13-25. PubMed ID: 22140607
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Involvement of P2X receptors in the NAD(+)-induced rise in [Ca (2+)] (i) in human monocytes.
    Grahnert A; Klein C; Hauschildt S
    Purinergic Signal; 2009 Sep; 5(3):309-19. PubMed ID: 19221895
    [TBL] [Abstract][Full Text] [Related]  

  • 73. N-type and P/Q-type calcium channels regulate differentially the release of noradrenaline, ATP and beta-NAD in blood vessels.
    Smyth LM; Yamboliev IA; Mutafova-Yambolieva VN
    Neuropharmacology; 2009 Feb; 56(2):368-78. PubMed ID: 18824011
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glycosylphosphatidylinositol-anchored arginine-specific ADP-ribosyltransferase7.1 (Art7.1) on chicken B cells: the possible role of Art7 in B cell receptor signalling and proliferation.
    Terashima M; Takahashi M; Shimoyama M; Tanigawa Y; Urano T; Tsuchiya M
    Mol Cell Biochem; 2009 Jan; 320(1-2):93-100. PubMed ID: 18696216
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Invited Lectures : Overviews Purinergic signalling: past, present and future.
    Purinergic Signal; 2006 May; 2(1):1-324. PubMed ID: 18404494
    [No Abstract]   [Full Text] [Related]  

  • 76. Beta-nicotinamide adenine dinucleotide is an inhibitory neurotransmitter in visceral smooth muscle.
    Mutafova-Yambolieva VN; Hwang SJ; Hao X; Chen H; Zhu MX; Wood JD; Ward SM; Sanders KM
    Proc Natl Acad Sci U S A; 2007 Oct; 104(41):16359-64. PubMed ID: 17913880
    [TBL] [Abstract][Full Text] [Related]  

  • 77. NAD+ utilization in Pasteurellaceae: simplification of a complex pathway.
    Gerlach G; Reidl J
    J Bacteriol; 2006 Oct; 188(19):6719-27. PubMed ID: 16980474
    [No Abstract]   [Full Text] [Related]  

  • 78. Extracellular NAD+ regulates intracellular calcium levels and induces activation of human granulocytes.
    Bruzzone S; Moreschi I; Guida L; Usai C; Zocchi E; De Flora A
    Biochem J; 2006 Feb; 393(Pt 3):697-704. PubMed ID: 16225456
    [TBL] [Abstract][Full Text] [Related]  

  • 79. NAD+ surfaces again.
    Ziegler M; Niere M
    Biochem J; 2004 Sep; 382(Pt 3):e5-6. PubMed ID: 15352307
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Extracellular NAD+ regulates intracellular free calcium concentration in human monocytes.
    Gerth A; Nieber K; Oppenheimer NJ; Hauschildt S
    Biochem J; 2004 Sep; 382(Pt 3):849-56. PubMed ID: 15233622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.